UiPath
PATH
357 hedge funds and large institutions have $5.56B invested in UiPath in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 135 increasing their positions, 95 reducing their positions, and 40 closing their positions.
201% more call options, than puts
Call options by funds: $109M | Put options by funds: $36.3M
73% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 40
42% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 95
40% more capital invested
Capital invested by funds: $3.97B → $5.56B (+$1.6B)
35% more funds holding in top 10
Funds holding in top 10: 17 → 23 (+6)
6% more funds holding
Funds holding: 336 → 357 (+21)
0.92% more ownership
Funds ownership: 66.47% → 67.39% (+0.92%)
Top Buyers
| 1 |
Holocene Advisors
New York
|
+$72.4M |
| 2 |
Millennium Management
New York
|
+$27M |
| 3 |
SM
Senvest Management
New York
|
+$19.8M |
| 4 |
Coatue Management
New York
|
+$17.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.5M |
Top Sellers
PATH Hedge Fund Activity: Q1 2023 in Review
357 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in UiPath (PATH) for Q1 2023, worth a combined $5.56B — up 40% from $3.97B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new PATH positions and 40 closed out — a net gain of 29 holders — while 135 added to existing stakes and 95 trimmed.
The largest buyer was Holocene Advisors, adding an estimated $72.4M. The largest seller was SC US (TTGP), cutting an estimated $65.2M.
- 357 institutional investors held UiPath (PATH) as of Q1 2023, up from 336 in Q4 2022.
- Funds reported $5.56B of UiPath stock for Q1 2023, up 40% quarter-over-quarter.
- 69 funds opened new UiPath positions in Q1 2023 and 40 closed out, a net change of +29 holders.
- The largest UiPath buyer in Q1 2023 was Holocene Advisors, an estimated $72.4M added.
- The largest UiPath seller in Q1 2023 was SC US (TTGP), an estimated $65.2M sold.
Based on aggregated 13F filings for Q1 2023.